Context Therapeutics Inc.

NASDAQ: CNTX · Real-Time Price · USD
0.78
0.04 (5.94%)
At close: Aug 15, 2025, 11:53 AM

Context Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-34.21M -27.64M -26.73M -30.15M -18.57M -21.32M -23.96M -20.75M -18.73M -17.71M -14.84M -14.37M -11.96M -13M -10.46M -8.15M -7.58M 4.93M
Depreciation & Amortization
13.87K 12.37K 10.88K 10.52K 10.79K 11.42K 12.04K 12.67K 12.77K 12.46K 9.27K 6.07K 2.88K n/a n/a n/a n/a n/a
Stock-Based Compensation
1.13M 895.58K 841.87K 866.1K 908.04K 1.03M 1.08M 1.06M 1.09M 1.04M 976.44K 937.18K 822.49K 700.52K 511.08K 337.52K 206.51K 117.79K
Other Working Capital
-2.49M -2.27M -2.53M -1.57M -139.94K -266.62K 329.03K 1.52M -484.52K -150.19K 510.37K -775.94K -1.05M -1.1M -1.36M 373K 1.42M 1.21M
Other Non-Cash Items
27.51M 14.82M 14.79M 14.47M -286.5K -264.13K -242.05K 73.75K 87.73K 586.58K 578.52K 538.5K 392.68K 3.33M 3.37M 3.4M 3.75M -7.84M
Deferred Income Tax
n/a n/a n/a 294.02K 294.02K 294.02K 294.02K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-1.28M -3.32M -3.48M -2.37M -764.06K 568.49K 1.78M 1.85M 260.87K 605.23K -277.52K -1.69M -889.32K -1.93M -2.22M 393.82K -697.8K 230.27K
Operating Cash Flow
-6.84M -15.22M -14.56M -16.88M -18.4M -19.68M -21.05M -17.75M -17.28M -15.46M -13.55M -14.58M -11.63M -10.9M -8.8M -4.01M -4.32M -2.56M
Capital Expenditures
-41.27K -41.26K -7.32K -7.32K 4.00 n/a n/a n/a -500K -501.84K -536.84K -536.84K -36.84K -35K n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-14.75M -14.75M -14.75M -14.75M n/a n/a n/a n/a -500K -500K -500K -750K -250K -500K -500K -250K -250K n/a
Investing Cash Flow
-14.79M -14.79M -14.76M -14.76M n/a n/a n/a n/a -500K -501.84K -536.84K -786.84K -286.84K -535K -500K -250K -250K n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 124.05K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-15.27K 94.79M 94.8M 94.8M 94.8M n/a n/a n/a -102.07K -102.07K -204.14K 54.02M 53.31M 53.31M 53.41M -816.92K n/a 200K
Financial Cash Flow
14.48M 109.28M 109.29M 94.76M 94.8M n/a n/a n/a -102.07K -102.07K -204.14K 54.02M 53.31M 55.26M 58.39M 4.52M 5.78M 4.16M
Net Cash Flow
-18.02M 79.26M 79.98M 63.12M 76.4M -19.68M -21.05M -17.75M -17.78M -15.96M -14.19M 39.01M 41.64M 44.07M 49.34M 252.09K 1.21M 1.6M
Free Cash Flow
-21.63M -30.02M -29.31M -31.63M -18.4M -19.68M -21.05M -17.75M -17.78M -15.96M -14.09M -15.12M -11.67M -10.94M -8.8M -4.01M -4.32M -2.56M